LATAM Artesunate Market Size & Outlook, 2026-2034


LATAM Artesunate Market Insights

  • As per Reed Intelligence insights, LATAM’s Artesunate Market was valued at USD 35.67 Million in 2025 and is anticipated to expand to USD 64.98 Million by 2034.
  • From 2026 to 2034, the market is anticipated to expand at a CAGR of 6.92%.
  • Within Formulation, Injectable Artesunate accounted for the largest market size in 2025.
  • During the forecast period, Oral Artesunate is anticipated to remain the highest-growth segment within the Formulation category.

Other Key Findings


  • The global Artesunate Market size saw LATAM holding a share of 6.86% in 2025.
  • United States is forecasted to account for the leading share of the global market by 2034.
  • In LATAM, Brazil is forecasted to be the fastest-expanding market, projected to reach USD 25.44 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 35.67 Million
Market Size In 2034 USD 64.98 Million
Largest segment Injectable Artesunate
Units Revenue in USD Million
CAGR 6.92% (2026-2034)
Segmnetation Covered
LATAM
  1. Brazil
  2. Mexico
  3. Argentina
  4. Colombia
  5. Chile
Formulation
  1. Injectable Artesunate
  2. Oral Artesunate
Application
  1. Severe Malaria Treatment
  2. Uncomplicated Malaria Treatment
End-Use
  1. Hospitals
  2. Clinics
  3. Retail Pharmacies
Distribution Channel
  1. Government Supply Programs
  2. Private Sector Distribution
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends